HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Valdez, V. A. Articles by Jacobstein, J. G. Search for Related Content PubMed PubMed Citation Articles by Valdez, V. A. Articles by Jacobstein, J. G.

Decreased Bone Uptake of Technetium-99m Polyphosphate in Thalassemia Major

The New York Hospital-Cornell Medical Center, New York, New York

Correspondence: For reprints contact: Virgilio A. Valdez, Div. of Nuclear Medicine, The New York Hospital-Cornell Medical Center, 525 East 68th St., New York, NY 10021.

ABSTRACT

Bone scans were performed with Tc-99m stannous polyphosphate on four patients with thalassemia major. Three of the scans show generalized decrease in skeletal uptake of the radiopharmaceutical, associated with renal enlargement and markedly increased renal radioactivity. The skeletal findings are consistent with the known bone abnormalities in thalassemia major, which are secondary to the extensive marrow hyperplasia and include loss of trabeculae and cortical thinning with consequent loss of bone mass. The increased renal uptake is probably due in part to the increased renal excretion (secondary to the poor bone uptake) and in part to the tubular dilatation and renal enlargement associated with thalassemia major. In addition, the presence of excessive amounts of iron in these patients may play a role in both the skeletal and renal findings.